Spero Therapeutics (NASDAQ:SPRO) is set to give its latest quarterly earnings report on Wednesday, 2024-03-13. Here’s what investors need to know before the announcement.
Analysts estimate that Spero Therapeutics will report an earnings per share (EPS) of $-0.10.
Spero Therapeutics bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the …